Detalles de la búsqueda
1.
DNA mismatch repair and microsatellite instability in colorectal tumors: an observational study in the Veterans Affairs Health Care System.
Future Oncol
; 18(6): 649-660, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068195
2.
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.
Mod Pathol
; 34(3): 532-541, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239737
3.
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Lancet Oncol
; 21(10): 1353-1365, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919526
4.
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.
Acta Oncol
; 59(6): 666-672, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079442
5.
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.
Br J Cancer
; 119(2): 153-159, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955135
6.
Tumour mutational burden in treatment-resistant tumours - Authors' reply.
Lancet Oncol
; 21(12): e552, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33271109
7.
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.
JTO Clin Res Rep
; 4(1): 100431, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793385
8.
Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab.
J Mol Diagn
; 24(6): 600-608, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218944
9.
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101941
10.
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study.
Clin Cancer Res
; 28(16): 3489-3498, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657979
Resultados
1 -
10
de 10
1
Próxima >
>>